www.fgks.org   »   [go: up one dir, main page]

Last update:

Oncology & Cancer news

Medications

Small molecule drug reverses ADAR1-induced cancer stem cell cloning capacity

Researchers at University of California San Diego School of Medicine, Sanford Stem Cell Institute and Moores Cancer Center report that a late-stage, pre-clinical small molecule inhibitor, called rebecsinib, reverses malignant ...

Oncology & Cancer

Scientists make breakthrough for 'next generation' cancer treatment

Scientists at the University of East Anglia are a step closer to creating a new generation of light-activated cancer treatments. The futuristic-sounding treatment would work by switching on LED lights embedded close to a ...

Medications

Researchers use a new approach to hit an 'undruggable' target

The protein STAT5 has long been an appealing target against cancer, but after decades of research it was consigned to the "undruggable" category. Now, University of Michigan Rogel Cancer Center researchers have found success ...

Oncology & Cancer

New insights into the drivers of glioma-related epilepsy

Glioma is one of the most aggressive malignant primary brain tumors. A common feature of glioma is the presence of localized, intermittent seizures referred to as glioma-related epilepsy, which is known to promote tumor growth. ...

Oncology & Cancer

Breast cancer risk models may incorrectly classify many women

Breast cancer risk estimates for individual women vary substantially depending on which risk assessment model is used, and women are likely receiving vastly different recommendations depending on the model used and the cutoff ...

Oncology & Cancer

AI with infrared imaging enables precise colon cancer diagnostics

The immense progress in the field of therapy options over the past years has significantly improved the chances of cure for patients with colon cancer. However, these new approaches, such as immunotherapies, require precise ...

Medical research

Conundrum solved over HPV link with head and neck cancer

A major international trial published in The Lancet Oncology has looked at studies from 13 head and neck cancer centers from nine countries around the world. Using the data of 7,895 patients, a research team has found that ...

Quantcast